September 17, 2024 Maria Dranishnikova Maker of dental cleaning systems loses 65% of value in four days
September 16, 2024 Maria Dranishnikova Shares of HeartSciences get a bump from announcement of non-dilutive financing
September 16, 2024 Maria Dranishnikova Implant maker Tenon Medical nearly triples its market capitalization in two days
September 12, 2024 Maria Dranishnikova Smart city solutions provider Gatekeeper gains on preliminary financials
September 12, 2024 Maria Dranishnikova Shares of SpaceX’s small competitor now up over 1,300% since April
September 11, 2024 Maria Dranishnikova Micro-cap Tonix Pharmaceuticals massively undervalued amid monkeypox outbreak — Zacks
September 11, 2024 Maria Dranishnikova Best-selling drugs in pill form: How Lexaria plans to make it big on weight-loss wave
September 10, 2024 Maria Dranishnikova Shares of pre-prepared food maker Mama’s Creations rise after new COO announced
September 9, 2024 Maria Dranishnikova Zacks spotlights three stocks poised to benefit from booming tech services market
September 9, 2024 Maria Dranishnikova Satellite communication systems maker SatixFy halves net loss in first half
September 6, 2024 Maria Dranishnikova Citius Oncology stock jumps after its drug included in clinical guidelines
September 6, 2024 Maria Dranishnikova Amazon for patriots: How PSQ Holdings is monetizing Trump campaign slogans
September 5, 2024 Maria Dranishnikova Display manufacturer Daktronics retreats after first-quarter financials
September 5, 2024 Maria Dranishnikova Athira stock plummets after its Alzheimer’s treatment fails in trials
September 4, 2024 Maria Dranishnikova Eyewear retailer KITS upgrades revenue guidance after strong August
September 4, 2024 Maria Dranishnikova Less-lethal weapons maker Byrna preliminarily reports 200% revenue growth, stock soars
September 4, 2024 Maria Dranishnikova Haypp could lose 20% of sales in Stockholm city crackdown on snus
September 3, 2024 Maria Dranishnikova Barchart.com contributor fingers small AI company with 79% upside
September 3, 2024 Maria Dranishnikova Insider Monkey names seven AI penny stocks most popular with hedge funds
September 2, 2024 Maria Dranishnikova Zacks spotlights cancer and sepsis test developer VolitionRx as undervalued
August 30, 2024 Maria Dranishnikova Value of company developing kidney disease treatments doubles in one day